HIMS
Overvalued by 113.6% based on the discounted cash flow analysis.
Market cap | $12.19 Billion |
---|---|
Enterprise Value | $12.09 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.58 |
Beta | 1.85 |
Outstanding Shares | 221,989,327 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 76.38 |
---|---|
PEG | 22.16 |
Price to Sales | 7.1 |
Price to Book Ratio | 28.39 |
Enterprise Value to Revenue | 6.77 |
Enterprise Value to EBIT | 113.87 |
Enterprise Value to Net Income | 73 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.32 |
No data
No data
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...